HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites
 


Bristol Myers Squibb Company News

Thu, 03 Nov 2016 06:26:07 GMT
INNATE PHARMA : Third quarter 2016 report - ForexTV  -  ForexTV.com
Innate Pharma SA (the “Company” – Euronext Paris: FR0010331421 – IPH) today announces its revenues and cash position for the first nine months of 2016.
Thu, 03 Nov 2016 05:05:48 GMT
Analyst's Overview about Earnings Estimates: Bristol-Myers Squibb Company (NYSE:BMY) , Array BioPharma Inc ...  -  Is stories
On 11/2/2016, Bristol-Myers Squibb Company (NYSE:BMY) dropped -0.45% and ended at $50.57. The stock's market capitalization arrived at $84.51B and total traded volume was 8.2 million shares. The stock has a 52-week highest price of $77.12 and its ...
Thu, 03 Nov 2016 00:07:31 GMT
Is this Large Market Cap Stock target price reasonable for Bristol-Myers Squibb Company (NYSE:BMY)?  -  The Daily Leicester
The company in question is, Bristol-Myers Squibb Company (NYSE:BMY) currently with a stock price of 50.8 (-0.22% today). The market cap for Bristol-Myers Squibb Company is 85327.23, and is in the sector Healthcare, and Drug Manufacturers – Major ...
Wed, 02 Nov 2016 21:34:25 GMT

With more marketing spend behind it, Eliquis gains on market leader Xarelto  -  Medical Marketing and Media
Johnson & Johnson's novel oral anticoagulant Xarelto, the current market leader in the category, may not hold pole position these among blood thinners for much longer, according to new prescription data. Eliquis, marketed by Bristol-Myers Squibb and ...
Wed, 02 Nov 2016 19:24:18 GMT
Bristol-Myers Squibb Co. (BMY) Price Target Cut to $52.00  -  DailyQuint
Bristol-Myers Squibb Co. (NYSE:BMY) had its target price reduced by stock analysts at Deutsche Bank AG from $59.00 to $52.00 in a report issued on Friday. The firm currently has a “hold” rating on the biopharmaceutical company's stock. Deutsche Bank ...
Wed, 02 Nov 2016 18:47:56 GMT
Bristol-Myers Squibb Company (NYSE:BMY) Analyst Estimates  -  The Independent Republic
Bristol-Myers Squibb Company (NYSE:BMY) stock is presently standing at about $50.80 and lots of equity research firms seem to have a target price set on the stock. The median one-year price target of 23 analysts covering the company is $62.00, which ...
Wed, 02 Nov 2016 17:20:17 GMT
Bristol-Myers Squibb Company (NYSE:BMY) Accounts Payable At $1407  -  RealistInvestor.com
Bristol-Myers Squibb Company (NYSE:BMY) accounts payable was $1407 millions for the year closed 2016-09-30. It was $1407 millions for the quarter concluded 2016-09-30. For the year ended 2016-09-30, the deviation in accounts payable was $593 ...
Wed, 02 Nov 2016 17:02:59 GMT
Stuck Under the Trend Line, Shares Look For Reversal: Bristol-Myers Squibb Company (NYSE:BMY)  -  AR News
Shares of Bristol-Myers Squibb Company (NYSE:BMY) have been on a recent steady downtrend, causing some worry for shareholders. In order to gauge which way a stock is trending, you must compare a stock's share price to its moving average. Uptrending ...
Wed, 02 Nov 2016 16:59:44 GMT
Market Call Tonight: Top Picks from Middlefield's Rob Lauzon Add to ...  -  The Globe and Mail
Rob Lauzon, deputy chief investment officer at Middlefield Capital Corporation, shares his top picks: Bristol-Myers Squibb, RioCan REIT and Bank of America. EMAIL THIS. Share. Copy link to video. Embed This Video. BNN Video | Nov. 02 2016
Wed, 02 Nov 2016 16:56:33 GMT
Stock Price Target For Bristol-Myers Squibb Company (NYSE:BMY)  -  Stock Observer
After completing a thorough study on Bristol-Myers Squibb Company (NYSE:BMY) fundamentals and technical, the Wall Street analysts have given its stock a price target of $63.285. This estimate is the result of Zacks poll, which included 14 experts.